Hans-Peter Hasler

Hans-Peter Hasler is the founder of Vicarius Pharma AG, founded in 2016, where the title held is Director since 2020.
Current jobs include Chairman at HBM Healthcare Investments AG since 2009; Non-Executive Chairman at Shield Therapeutics Plc since 2020; Chairman at Medical Imaging Analysis Center since 2012; Independent Director at Gain Therapeutics, Inc. since 2021; Independent Director at Minerva Neurosciences, Inc. since 2017; and Principal at Hph Management GmbH.
Former jobs include Vice Chairman at Santhera Pharmaceuticals Holding AG from 2006 to 2011; Director at Acino International AG from 2008 to 2013; Independent Non-Executive Director at Dr. Reddy's Laboratories Ltd. from 2016 to 2018; Managing Director at Wyeth Pharma GmbH; Director at Ferring Holding SA; Director at Ferring International Center SA; Independent Director at Celltrion, Inc.; Managing Director at Wyeth Pharmaceuticals AG from 1993 to 1998; Director at Canyon Pharmaceuticals AG; Director at AOP Orphan Pharmaceuticals GmbH; Managing Director at Wyeth-lederle Pharma GmbH; Director at Dr. Reddy's Laboratories SA; Independent Non-Executive Director at Patheon NV from 2016 to 2017; Director at Rigi Healthcare AG; Chief Marketing Officer at Wyeth LLC; Executive Vice President-International at Biogen MA, Inc.; Chief Operating Officer at Elan Corp.
Plc from 2012 to 2014; COO, EVP, Head-Global Neurology & International at Biogen, Inc. from 2003 to 2009; Chief Marketing Officer & Senior Vice President at Wyeth Pharmaceuticals LLC from 1998 to 2001; Chief Operating Officer at Biogen Idec, Inc. (North Carolina) from 2001 to 2009.
Education includes undergraduate studies at Schweizerisches Institut für Betriebsökonomie AG.